The loss of Vericel under GAAP for the 3 months of 2022 was $7.091 million, up 2.2 times from $3.289 million in the previous year. Revenue increased by 4.4% to $36.074 million from $34.568 million a year earlier.

Vericel's GAAP loss for 2021 was $7.471 million, compared to a profit of $2.864 million in the previous year. Revenue increased 25.8% to $156.184 million from $124.179 million a year earlier.

Vericel's GAAP loss for 9M 2021 was $12.006 million, up 28.3% from $9.356 million in the previous year. Revenue increased 37.5% to $108.593 million from $78.95 million a year earlier.

Vericel's GAAP loss for 6 months of 2021 was $7.075 million, down 45.5% from $12.974 million in the previous year. Revenue increased 58.7% to $74.087 million from $46.692 million a year earlier.